Covey Michael Sean Merrill sold $123K of FC

Covey Michael Sean Merrill (Chief Product Officer) sold 8,000 shares of FRANKLIN COVEY CO (FC) at $15.42 ($0.12M total) on 2026-11-10.

Original reporting
SEC EDGAR · Covey Michael Sean Merrill
Published Nov 12, 2026, 9:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FC
Bearish
medium confidence
Mentioned
$FC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FCBearishLow
01

Why it matters

The transaction is a primary disclosure but modest in size, offering limited trading impetus.

02

Market read

Small insider sell with limited price impact; useful for short‑term monitoring.

03

What to watch

The insider retains a large stake (over 200k shares) indicating continued confidence.

Relevance 4/10Novelty 4/10Timing: after-hours filing on 2026-11-12

Background

Form 4 disclosures provide the first public record of insider transactions.

Company-level read

Ticker impact

$FCBearishMedium confidence
Context

Chief Product Officer Michael Sean Covey sold 8,000 shares for $123,400 in a Form 4 filing.

Expected impact

likely slight pressure as the market prices in the insider sell

Evidence & confidence

The sale is small relative to holdings and not part of a pre‑arranged plan, but any insider sell can prompt short‑term downside.

Market effects

Minimal impact on the consumer‑services sector.

No broader regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Franklin Covey Co

    US‑listed provider of training and consulting services (ticker FC).

  • Michael Sean Covey

    Chief Product Officer of Franklin Covey.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FCMed

Franklin Covey (FC) Q4 2026 Earnings Call Transcript

Franklin Covey (FC) reported Q4 2026 growth in Enterprise North America, with invoiced amounts up 4% to $151.4M and deferred revenue up 17% to $59.2M. The company expects fiscal 2027 revenue and adjusted EBITDA growth, driven by a resilient core and successful go-to-market transformation. Education business is expected to return to growth, and AI trends support the company's durability.

$FCMed

Franklin Covey Co (FC) (Q4 2026) Earnings Call Highlights: Navigating Revenue Headwinds

Franklin Covey (FC) reported China as 2% of fiscal 2026 revenue, with a transition to a licensee model expected to reduce revenue by $2 million but remain EBITDA neutral. CFO Jesse guided to 45-50% of annual revenue in the first half of fiscal 2027, with restructuring savings increasing EBITDA through the year. CEO Paul Walker noted improved revenue retention and plans to expand the sales team by over 20%.

$FCMed

Franklin Covey Co. Q3 2026 Earnings Call Summary

Franklin Covey Co. reported Q3 2026 momentum driven by higher client retention/expansion and North America enterprise growth, including a third straight quarter of rising invoiced amounts. Services booking pace rose 25% YTD. Fiscal 2027 outlook calls for faster revenue growth and operating leverage, but revenue guidance was cut ~$6M due to timing, education budget, and geopolitical impacts; gross margin fell to 73.9% from 76.5%.

$FCMedAI 8/10

Why Franklin Covey Stock Plummeted Today

Franklin Covey (FC) shares fell 12.9% on Thursday after the company reported Q3 FY2026 results (ended May 31) below Wall Street expectations and issued weaker-than-expected forward guidance. EPS was $0.27 on sales of $67.8M vs estimates of about $0.31 on ~$68.3M revenue; guidance called for $260M–$267M sales vs prior $265M–$275M.